PharmaShots
Jul 3, 2026, 8:30 AM
CSPC Group and AstraZeneca Partner to Develop siRNA Drugs in ~$1.77B Deal
Shots: Ref: CSPC  |  Image: CSPC & AstraZeneca | Press Release Related News: CSPC Pharmaceutical and AstraZeneca Seal ~$18.5B Long-Acting Peptide Deal for Obesity PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post CSPC Group and AstraZeneca Partner to Develop siRNA Drugs in ~$1.77B Deal appeared first on PharmaShots.
Read more

